Solaris Pharma Corporation

Executive Summary

Solaris Pharma Corporation is a private specialty pharmaceutical company based in San Diego, founded in 2018. The company focuses on identifying, developing, and marketing high-quality generic and specialty pharmaceutical products, with an emphasis on complex formulations that offer competitive advantages. Solaris Pharma employs an experienced R&D and management team dedicated to a 'right-first-time' development approach, ensuring quality and efficiency. With a strong financial position and a niche market strategy, the company aims to become a pacesetter in the specialty generic pharmaceutical space. While details on specific products and pipeline are limited, Solaris Pharma's commitment to quality and its experienced team position it well for growth in the competitive generic drug market.

Upcoming Catalysts (preview)

• Q3 2026FDA approval of a complex generic product55% success
• Q4 2026Strategic partnership or licensing deal for specialty products50% success
• Q2 2026Initiation of a new R&D program for a high-barrier generic70% success